Washington, D.C. 20549



Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

May 13, 2021

Date of Report (Date of earliest event reported)

(Exact name of Registrant as specified in its charter)
Delaware 001-38334 94-3180138
(State or other jurisdiction
of incorporation)
file number)
 (I.R.S. Employer
Identification No.)

330 Townsend Street, Suite 234, San Francisco, CA 94107

(Address of principal executive offices and zip code)

(408) 467-1900
(Registrant’s telephone number, including area code)


(Former name or former address, if changed since last report.) 

Check the appropriate box below if the Form 8‑K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value per shareIMMRThe NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§240.12b–2 of this chapter).

Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


Effective May 21, 2021, Mike Okada will depart as General Counsel & Senior Vice President, IP Licensing and Legal Affairs of Immersion Corporation (the “Company”).


The Company and Mr. Okada entered into a Separation Agreement dated May 17, 2021 (the “Separation Agreement”), pursuant to which, in consideration for the execution of customary general releases in favor of the Company and Mr. Okada’s continuing observation and performance of the terms of the Separation Agreement:

• Mr. Okada will receive a lump sum payment in the amount of $171,450, subject to all legally required payroll withholdings;

• 12,967 unvested shares of the Company’s Common Stock subject to a restricted stock award granted to Mr. Okada on July 15, 2019 will accelerate and become vested; and

• The Company will pay COBRA premiums necessary to continue Mr. Okada’s and his dependents’ group health insurance coverage until the earlier of (i) November 21, 2021, or (ii) the date on which Mr. Okada first becomes eligible to obtain other group health insurance coverage.

The Separation Agreement is filed herewith as Exhibit 10.1, and the terms of the Separation Agreement are incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

Immersion Corporation held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) on May 13, 2021. At the Annual Meeting, the following proposals were adopted as follows:

1.    The election of four (4) directors, Sumit Agarwal, William Martin, Eric Singer, and Mary Dotz, each to serve until the 2022 Annual Meeting of Stockholders and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal:

NomineeShares ForShares WithheldBroker Non-Votes
Sumit Agarwal12,963,820 628,992 5,665,277 
William Martin13,216,542 376,270 5,665,277 
Eric Singer13,121,527 471,285 5,665,277 
Mary Dotz13,446,096 146,716 5,665,277 

2.    Ratification of the Appointment of Armanino LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021:

Shares ForShares AgainstShares AbstainingBroker Non-Votes
18,428,496 815,973 13,620 0

3.    Advisory vote on the compensation of the Company’s named executive officers:

Shares ForShares AgainstShares AbstainingBroker Non-Votes
12,941,114 610,821 40,877 5,665,277.00 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
Exhibit No.
Exhibit Title


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 17, 2021By: /s/ AARON AKERMAN
 Name:     Aaron Akerman
 Title:     Chief Financial Officer